Jo Wiederhorn responds to a New York Daily News editorial: Investing in biomedical research is indeed smart (“Death by a thousand cuts,” editorial, May 18). As federal funding has declined, however, other states have recognized the wisdom of investing in research. California, Texas and Massachusetts are spending billions to grow their bioscience sectors, and are… Read More

State medical schools use a variety of funding sources for research, but officials are not getting as much money as they’d like in the state budget. Universities say this limits their ability to recruit and retain researchers. Jo Wiederhorn, President of the Associated Medical Schools of New York, took part in this interview which is… Read More

New York, with its remarkable range of health care facilities and options, still suffers from a shortage of doctors. An interesting cause of the shortage is that doctors are being poached – lured to other states offering higher salaries, more up-to-date facilities and funding for research. Watch the interview here.

New York has long been a global leader in biomedical research and development. Our state’s 16 medical schools contribute to that position by employing some of the most innovative, talented and prolific researchers in the field. In fact, New York is home to 26 Nobel Laureates in medicine and physiology. But now, our state’s standing… Read More

TV 10/55’s Long Island Bureau Chief spoke with top researchers about a possible ‘brain drain’ on Long Island. Watch the interview with Jo Wiederhorn, AMSNY’s President and CEO, here.

Dr. Rudolph Leibel, a man who has won international acclaim for his study of how genes impact obesity and type-2 diabetes, is warning that New York isn’t doing enough to keep its most brilliant medical researchers in the state. Read more on this plus Jo Wiederhorn’s input here.